Corzide is nadolol and bendroflumethiazide. Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.
Contra-indicated in patients with bronchial asthma, sinus bradycardia and greater than first degree conduction block, cardiogenic shock, and overt cardiac failure.
- TRADE NAMES: Apo-Nadolol; Corgard; Corzide (Monarch); Farmagard; Nadic; Solgol; Syn-Nadolol
- INDICATIONS: Hypertension, angina pectoris
- CLASS: Adrenergic beta-receptor antagonist, Antiarrhythmic class II
- HALF-LIFE: 10–24 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Clonidine, Epinephrine, Verapamil
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/08/2024
